$CRSP Crispr Therapeutics - big hammer candlestick today holding the lower limit of a bullish channel which began in January. Expecting continuation bounce in the very near term. See chart for two possible medium term targets by next earnings release in August. Stop loss - $56.00 Note - Observation/opinion, not investment advice.
Another pharma stock that just crossed on MACD. Looking for a nice run with this one.
Was looking at this back in January at ~ $27/share, mentioned it again at $50/share, now might be the last big time to get in on the climb. Shoot your shots boys. NASDAQ:CRSP
This chart looked good in January when the market was on fire, and it still continues to look good despite hiccups along the way! Bullish.
CRSP Gains, gains, more gains. Looking good so far this year. Gene editing seeking to cure diseases and cancer. Don't sleep on this one. Hitting some all time highs right now so wait for a moment to get down to the $22's and $21's and watch for a good return in the future.